nonalcohol
fatti
liver
diseas
nafld
chronic
liver
diseas
found
worldwid
present
studi
aim
evalu
mechan
inhibit
lipid
accumul
free
fatti
acid
ffa
treat
cell
caus
bark
fruit
extract
toona
sinensi
tsb
tsf
ffa
induc
lipid
triglycerid
tg
accumul
attenu
tsb
tsf
tsb
andor
tsf
promot
phosphoryl
ampactiv
protein
kinas
ampk
acetylcoa
carboxylas
peroxisom
proliferatoractiv
receptor
alpha
upregul
furthermor
tsb
tsf
suppress
ffainduc
liver
x
receptor
sterol
regulatori
elementbind
transcript
protein
fatti
acid
synthas
stearoylcoa
desaturas
protein
express
moreov
tsb
andor
tsf
induc
phosphoryl
like
autophagyactiv
kinas
microtubuleassoci
protein
chain
express
therefor
tsb
tsf
reliev
lipid
accumul
attenu
lipogen
protein
express
activ
ampk
pathway
upregul
autophag
flux
enhanc
lipid
metabol
moreov
tsb
tsf
reduc
tg
content
impli
therapeut
use
tsb
tsf
nafld
specif
transport
protein
undergo
hyperinsulinemia
directli
inhibit
ffa
promot
hepat
de
novo
lipid
synthesi
upregul
sterol
regulatori
elementbind
carbohydr
respons
elementbind
protein
recent
studi
appli
vitro
approach
determin
molecular
mechan
involv
hepat
steatosi
progress
emerg
evid
suggest
ampactiv
protein
kinas
ampk
peroxisom
proliferatoractiv
receptor
alpha
critic
regul
hepat
lipid
metabol
could
therapeut
target
nafld
target
protein
exhibit
interact
exampl
phosphoryl
ampk
activ
acetylcoa
carboxylas
acc
autophagi
activ
kinas
toona
sinensi
juss
roem
decidu
tree
wide
distribut
southeast
asia
cultiv
mani
part
world
whole
plant
use
herbal
remedi
tender
leav
use
dish
sauc
sever
year
hundr
phytochem
compound
identifi
sinensi
includ
polyphenol
phenol
acid
flavonoid
stilben
lignan
terpenoid
sterol
report
aqueou
extract
leav
sinensi
exhibit
mani
biolog
function
antivir
antibacteri
antidiabet
antiobes
hepatoprotect
anticanc
function
howev
littl
known
part
sinensi
preliminari
result
demonstr
among
root
leav
bark
fruit
sinensi
bark
fruit
could
block
lipid
accumul
hepatocyt
shown
diet
sinensi
leav
root
bark
tsb
enhanc
sperm
qualiti
improv
memori
senescenceacceler
mice
sinensi
fruit
tsf
extract
exhibit
strong
antioxid
effect
protect
kidney
diabet
nephropathi
present
studi
investig
molecular
mechan
effect
tsb
tsf
extract
lipid
accumul
use
vitro
cellular
model
nonalcohol
fatti
liver
diseas
nafld
global
health
issu
driven
dysregul
lipid
homeostasi
nafld
multifactori
diseas
caus
excess
alcohol
consumpt
patholog
accumul
triacylglycerol
hepatocyt
excess
import
diminish
export
oxid
free
fatti
acid
ffa
hepatocyt
caus
hepat
steatosi
hepat
triglycerid
tg
accumul
glycerol
ffa
esterif
unknown
reason
patient
develop
nonalcohol
steatohepat
sever
case
liver
fibrosi
cirrhosi
even
hepatocarcinoma
nafld
present
metabol
liver
disord
imbal
lipid
metabol
liver
insulin
fail
inhibit
lipolysi
adipos
tissu
increas
efflux
ffa
circul
uptak
liver
ffa
transport
mitochondri
matrix
bromid
obtain
genemark
gmbiolab
co
ltd
taichung
taiwan
ffa
purchas
sigmaaldrich
compani
st
loui
mo
usa
fenofibr
chloroquin
obtain
cayman
cayman
chemic
co
ann
arbor
mi
usa
compound
c
obtain
enzo
life
scienc
inc
farmingdal
ny
usa
toosendanin
purchas
wuhan
chemfac
biochem
co
ltd
wuhan
hubei
china
tsf
tsb
collect
local
spring
yulin
taiwan
identifi
professor
hsengkuang
hsu
physiologist
botanist
kaohsiung
medic
univers
taiwan
tsb
use
studi
obtain
plant
age
least
two
year
wherea
tsf
collect
sevenyearold
plant
collect
materi
wash
boil
twice
revers
osmosi
water
min
crude
extract
collect
freez
dri
form
powder
tsb
tsf
extract
dissolv
steril
phosphatebuff
salin
pb
ph
filter
use
syring
filter
sartoriu
stedim
biotech
inc
germani
determin
prevent
effect
tsb
tsf
lipid
accumul
cell
treat
tsb
andor
tsf
extract
h
ffa
ad
bovin
serum
albumin
bsa
sigma
media
anoth
h
control
group
expos
bsa
indic
time
period
investig
ampk
activ
compound
c
treat
cell
min
prior
ffa
ffa
tsb
ffa
tsf
cotreat
confirm
autophag
pathway
tsb
andor
tsf
pretreat
cell
h
prior
cotreat
chloroquin
human
hepatoma
cell
line
purchas
bioresourc
collect
research
center
hsinchu
taiwan
grown
dulbecco
modifi
eagl
medium
hyclon
brand
gener
electr
compani
boston
usa
contain
gl
glucos
unitsml
penicillin
streptomycin
foetal
bovin
serum
gibco
grand
island
ny
usa
humidifi
atmospher
co
c
cell
viabil
measur
quantit
colorimetr
assay
bromid
mtt
remov
media
mtt
solut
mgml
ad
well
h
incub
c
optic
densiti
od
measur
nm
micropl
reader
biotek
instrument
inc
winooski
vt
usa
fixat
formaldehyd
neutral
lipid
stain
use
oil
red
bio
basic
inc
amherst
ny
usa
isopropanol
min
remov
stain
solut
od
measur
nm
use
micropl
reader
biotek
cell
supplement
ffa
without
sinensi
extract
h
fix
formaldehyd
incub
min
nile
red
pb
od
measur
use
multimod
micropl
reader
biotek
tg
level
cell
lysat
determin
use
colorimetr
assay
cayman
chemic
ann
arbor
mi
usa
accord
manufactur
instruct
sever
pb
wash
scrape
cell
lysat
centrifug
g
min
cold
standard
diluent
assay
buffer
ad
resuspend
lysat
sonic
perform
time
puls
procedur
lysat
centrifug
g
min
pellet
store
refriger
c
use
treatment
cell
dish
wash
pb
collect
lysi
buffer
triton
mm
mgcl
mm
hepe
acid
mm
pipe
acid
mm
edta
ethylenediaminetetraacet
acid
mm
phenylmethylsulphonyl
fluorid
mm
sodium
fluorid
mm
sodium
orthovanad
mm
phosphat
mm
sodium
pyrophosph
aprotinin
pepstatin
leupeptin
ph
sonic
time
puls
protein
level
measur
use
protein
assay
kit
biorad
life
scienc
hercul
ca
usa
sampl
store
c
analysi
protein
sampl
load
lane
per
lane
sodium
dodecyl
sulphat
polyacrylamid
gel
subject
electrophoresi
transfer
nitrocellulos
membran
membran
block
h
room
temperatur
nonfat
milk
bsa
phosphoryl
antibodi
trisbuff
salin
tb
mm
nacl
mm
tri
base
ph
contain
tween
incub
overnight
c
desir
primari
antibodi
tabl
dilut
tb
tween
nonfat
milk
bsa
alkalin
phosphataseconjug
antirabbit
antimous
dilut
genetex
inc
irvin
ca
usa
bound
antibodi
detect
use
alkalin
phosphatas
stain
system
sigma
water
acquiti
uplc
system
water
corpor
milford
usa
coupl
tandem
ms
finnigan
tsq
quantum
ultra
triplequadrupol
ms
thermo
electron
san
jose
ca
usa
combin
xcalibur
softwar
thermofinnigan
bellefont
pa
usa
use
detect
quantifi
analyt
lcm
system
equip
electrospray
ion
sourc
ran
neg
mode
inject
volum
acquiti
uplc
csh
phenylhexyl
column
mm
mm
water
corpor
milford
usa
equip
filter
water
acquiti
beh
column
mm
mm
front
column
flow
rate
column
temperatur
c
solvent
acet
acid
water
acet
acid
acetonitril
b
total
phenol
determin
use
folinciocalteu
method
briefli
tsb
tsf
extract
sonic
methanol
room
temperatur
centrifug
rpm
min
two
microlit
sampl
supern
mix
ml
deioniz
water
folin
reagent
ad
tube
least
min
three
hundr
sodium
carbon
solut
ad
mix
thoroughli
h
incub
absorb
read
nm
multimod
micropl
reader
biotek
total
phenol
content
calcul
equat
total
phenol
concentr
extract
mgml
volum
extract
ml
weight
extract
g
analys
perform
least
three
time
valu
express
mean
standard
deviat
statist
differ
determin
kruskalw
test
correct
wilcoxon
sign
rank
control
vs
ffa
mannwhitney
test
graphpad
prism
softwar
version
graphpad
softwar
compani
san
diego
ca
usa
pvalu
consid
statist
signific
lcm
use
determin
level
possibl
activ
compound
tsb
tsf
extract
gallic
acid
abund
ingredi
tsb
ppb
tsf
ppb
extract
figur
rutin
found
tsb
ppb
tsf
ppb
extract
figur
quercetin
note
tsf
extract
ppb
figur
although
kaempferol
inhibit
ffainduc
lipid
accumul
present
two
extract
toosendanin
exhibit
extrem
low
amount
tsb
ppb
tsf
extract
ppb
figur
retent
time
compound
min
gallic
acid
min
rutin
quercetin
min
toosendanin
amount
total
phenol
mgg
gallic
acid
equival
tsb
mgg
gallic
acid
equival
tsf
respect
tabl
retent
time
compound
min
gallic
acid
min
rutin
quercetin
min
toosendanin
amount
total
phenol
mgg
gallic
acid
equival
tsb
mgg
gallic
acid
equival
tsf
respect
tabl
human
hepatoma
cell
line
use
mimic
ffainduc
steatosi
human
bodi
oleic
palmit
acid
abund
ffa
patient
steatosi
lipidladen
cell
model
establish
ad
differ
ffa
level
oleic
acid
mm
palmit
acid
mm
h
shown
figur
ffa
induc
lipid
accumul
concentrationdepend
manner
figur
human
hepatoma
cell
line
use
mimic
ffainduc
steatosi
human
bodi
oleic
palmit
acid
abund
ffa
patient
steatosi
lipidladen
cell
model
establish
ad
differ
ffa
level
oleic
acid
mm
palmit
acid
mm
h
shown
figur
ffa
induc
lipid
accumul
concentrationdepend
manner
figur
determin
tsb
tsf
inhibitori
effect
ffainduc
lipogenesi
tsb
tsf
extract
pretreat
cell
h
ffa
ad
cell
anoth
h
oil
red
nile
red
stain
confirm
tsb
tsf
reduc
ffainduc
lipogenesi
concentrationdepend
manner
figur
c
tsbtreat
group
lipid
content
reduc
level
compar
ffa
group
figur
upper
panel
tsftreat
group
lipid
content
reduc
level
compar
ffa
group
figur
lower
panel
cotreat
tsb
ffa
tsf
ffa
affect
cell
surviv
rate
figur
e
wherea
palmit
acid
alon
show
cytotox
cell
figur
investig
antilipogen
effect
ffatreat
cell
tg
level
examin
experiment
condit
shown
figur
tsb
tsf
significantli
inhibit
tg
express
cell
figur
b
renal
carcinoma
cell
use
neg
control
fenofibr
posit
control
determin
tsb
tsf
inhibitori
effect
ffainduc
lipogenesi
tsb
tsf
extract
pretreat
cell
h
ffa
ad
cell
anoth
h
oil
red
nile
red
stain
confirm
tsb
tsf
reduc
ffainduc
lipogenesi
concentrationdepend
manner
figur
c
tsbtreat
group
lipid
content
reduc
level
compar
ffa
group
figur
upper
panel
tsftreat
group
lipid
content
reduc
level
compar
ffa
group
figur
lower
panel
cotreat
tsb
ffa
tsf
ffa
affect
cell
surviv
rate
figur
e
wherea
palmit
acid
alon
show
cytotox
cell
figur
investig
antilipogen
effect
ffatreat
cell
tg
level
examin
experiment
condit
shown
figur
tsb
tsf
significantli
inhibit
tg
express
cell
figur
b
renal
carcinoma
cell
use
neg
control
fenofibr
posit
control
data
quantifi
three
twelv
independ
experi
express
mean
sd
p
compar
control
group
gml
p
compar
ffa
group
bd
p
figur
p
p
compar
contro
oil
red
stain
scale
bar
repres
imag
eight
independ
experi
b
c
quantif
lipid
content
df
mtt
assay
data
quantifi
three
twelv
independ
experi
express
mean
sd
p
compar
control
group
gml
p
compar
ffa
group
bd
p
figur
p
p
compar
contro
studi
tsb
tsf
mechan
ffainduc
lipid
accumul
cell
pretreat
tsb
andor
tsf
extract
examin
relat
lipogen
protein
express
includ
liver
x
receptor
lxr
acc
fatti
acid
synthas
fasn
stearoylcoa
desaturas
tsb
tsf
extract
significantli
inhibit
ffainduc
lxr
acc
fasn
express
figur
l
determin
whether
tsb
tsf
extract
inhibit
lipid
accumul
activ
ampk
pathway
cell
treat
tsb
andor
tsf
extract
h
phosphoryl
ampk
determin
western
blot
tsb
tsf
extract
significantli
increas
ampk
phosphoryl
h
figur
b
e
f
addit
tsb
tsf
extractinduc
ampk
phosphoryl
reduc
treatment
ampk
inhibitor
compound
c
figur
g
h
evalu
whether
ampk
phosphoryl
mediat
tsb
tsf
effect
lipid
accumul
ffatreat
hepatocyt
cell
treat
compound
c
min
prior
treatment
sinensi
extract
lipid
accumul
measur
h
ffa
exposur
use
oil
red
stain
level
tsb
tsf
significantli
inhibit
lipid
accumul
ffatreat
cell
effect
revers
compound
c
figur
ampk
pathway
activ
directli
promot
downstream
effector
includ
acc
phosphoryl
ppar
express
compar
control
group
ffa
group
decreas
ampk
acc
phosphoryl
level
figur
tsb
andor
tsf
treatment
phosphoryl
level
ampk
acc
enhanc
ffatreat
group
figur
similarli
ppar
express
downregul
ffa
treatment
upregul
tsb
andor
tsf
treatment
figur
studi
tsb
tsf
mechan
ffainduc
lipid
accumul
cell
pretreat
tsb
andor
tsf
extract
examin
relat
lipogen
protein
express
includ
liver
x
receptor
lxr
acc
fatti
acid
synthas
fasn
stearoylcoa
desaturas
tsb
tsf
extract
significantli
inhibit
ffainduc
lxr
acc
fasn
express
figur
l
immunoblot
lipogen
protein
express
tsb
tsf
pretreat
lipidladen
cell
gapdh
use
intern
control
cl
bar
graph
show
densitometr
data
mean
sd
three
eight
independ
experi
imag
shown
repres
one
experi
p
p
compar
control
group
con
p
p
p
compar
ffa
group
determin
whether
tsb
tsf
extract
inhibit
lipid
accumul
activ
ampk
pathway
cell
treat
tsb
andor
tsf
extract
h
phosphoryl
ampk
determin
western
blot
tsb
tsf
extract
significantli
increas
ampk
phosphoryl
h
figur
b
e
f
addit
tsb
tsf
extractinduc
ampk
phosphoryl
reduc
treatment
ampk
inhibitor
compound
c
figur
g
h
evalu
whether
ampk
phosphoryl
mediat
tsb
tsf
effect
lipid
accumul
ffatreat
hepatocyt
cell
treat
compound
c
min
prior
treatment
sinensi
extract
lipid
accumul
measur
h
ffa
exposur
use
oil
red
stain
level
tsb
tsf
significantli
inhibit
lipid
accumul
ffatreat
cell
effect
revers
compound
c
figur
k
immunoblot
lipogen
protein
express
tsb
tsf
pretreat
lipidladen
cell
gapdh
use
intern
control
cl
bar
graph
show
densitometr
data
mean
sd
three
eight
independ
experi
imag
shown
repres
one
experi
p
p
compar
control
group
con
p
p
p
compar
ffa
group
ampk
pathway
activ
directli
promot
downstream
effector
includ
acc
phosphoryl
ppar
express
compar
control
group
ffa
group
decreas
ampk
acc
phosphoryl
level
figur
tsb
andor
tsf
treatment
phosphoryl
level
ampk
acc
enhanc
ffatreat
group
figur
similarli
ppar
express
downregul
ffa
treatment
upregul
b
immunoblot
phosphoryl
ampk
acc
level
ampk
acc
gapdh
use
intern
control
cf
bar
graph
show
densitometr
data
mean
sd
three
ten
independ
experi
p
compar
control
group
con
p
p
compar
ffa
group
p
compar
ffa
group
c
bar
graph
show
densitometr
data
mean
sd
three
five
independ
experi
p
compar
control
group
con
p
p
compar
ffa
group
b
immunoblot
phosphoryl
ampk
acc
level
ampk
acc
gapdh
use
intern
control
cf
bar
graph
show
densitometr
data
mean
sd
three
ten
independ
experi
p
compar
control
group
con
p
p
compar
ffa
group
p
compar
ffa
group
b
immunoblot
phosphoryl
ampk
acc
level
ampk
acc
gapdh
use
intern
control
cf
bar
graph
show
densitometr
data
mean
sd
three
ten
independ
experi
p
compar
control
group
con
p
p
compar
ffa
group
p
compar
ffa
group
bar
graph
show
densitometr
data
mean
sd
three
five
independ
experi
p
compar
control
group
con
p
p
compar
ffa
group
bar
graph
show
densitometr
data
mean
sd
three
five
independ
experi
p
compar
control
group
con
p
p
compar
ffa
group
nafld
relat
dysregul
autophag
process
hepatocyt
investig
tsb
tsf
extract
effect
autophagi
cell
examin
determin
whether
tsb
andor
tsf
extract
induc
express
h
treatment
tsb
tsf
extract
significantli
induc
express
figur
b
e
f
moreov
express
larg
upregul
ad
autophagosom
inhibitor
chloroquin
tsband
tsftreat
cell
figur
g
h
determin
whether
tsb
tsf
extractinduc
autophagi
associ
decreas
lipid
content
cell
pretreat
tsb
andor
tsf
extract
h
cotreat
chloroquin
ffa
h
lipid
accumul
measur
oil
red
stain
tsb
tsf
extract
inhibit
ffainduc
lipid
accumul
effect
block
chloroquin
figur
nafld
relat
dysregul
autophag
process
hepatocyt
investig
tsb
tsf
extract
effect
autophagi
cell
examin
determin
whether
tsb
andor
tsf
extract
induc
express
h
treatment
tsb
tsf
extract
significantli
induc
express
figur
b
e
f
moreov
express
larg
upregul
ad
autophagosom
inhibitor
chloroquin
tsband
tsftreat
cell
figur
g
h
determin
whether
tsb
tsf
extractinduc
autophagi
associ
decreas
lipid
content
cell
pretreat
tsb
andor
tsf
extract
h
cotreat
chloroquin
ffa
h
lipid
accumul
measur
oil
red
stain
tsb
tsf
extract
inhibit
ffainduc
lipid
accumul
effect
block
chloroquin
figur
ampk
directli
regul
autophagi
phosphoryl
therebi
activ
four
phosphoryl
site
within
map
phosphoryl
site
report
activ
ampk
compar
control
ffa
inhibit
phosphoryl
figur
level
gml
tsb
andor
tsf
extract
significantli
enhanc
phosphoryl
ffatreat
cell
accompani
upregul
figur
f
ampk
directli
regul
autophagi
phosphoryl
therebi
activ
four
phosphoryl
site
within
map
phosphoryl
site
report
activ
ampk
compar
control
ffa
inhibit
phosphoryl
figur
level
tsb
andor
tsf
extract
significantli
enhanc
phosphoryl
ffatreat
cell
accompani
upregul
figur
f
determin
sinensi
activ
compon
regul
lipid
metabol
cell
pretreat
gallic
acid
quercetin
rutin
methyl
gallat
ethyl
gallat
kaempferol
toosendanin
prior
ffa
treatment
lipid
accumul
measur
h
ffa
exposur
nile
red
stain
effect
level
compound
nontox
cell
found
gallic
acid
rutin
quercetin
level
significantli
reduc
ffainduc
lipid
content
figur
wherea
ethyl
gallat
methyl
gallat
tannic
acid
nontox
level
effect
addit
toosendanin
level
significantli
reduc
ffainduc
lipogenesi
figur
immunoblot
phosphoryl
ulk
subunit
cf
bar
graph
show
densitometr
data
mean
sd
three
five
independ
experi
p
compar
control
group
con
p
p
compar
ffa
group
determin
sinensi
activ
compon
regul
lipid
metabol
cell
pretreat
gallic
acid
quercetin
rutin
methyl
gallat
ethyl
gallat
kaempferol
toosendanin
prior
ffa
treatment
lipid
accumul
measur
h
ffa
exposur
nile
red
stain
effect
level
compound
nontox
cell
data
shown
found
gallic
acid
rutin
quercetin
level
significantli
reduc
ffainduc
lipid
content
figur
wherea
ethyl
gallat
methyl
gallat
tannic
acid
nontox
level
effect
data
shown
addit
toosendanin
level
significantli
reduc
ffainduc
lipogenesi
figur
nile
red
stain
data
quantifi
three
eight
independ
experi
express
mean
sd
p
compar
control
group
con
p
p
compar
ffa
group
incid
nafld
vari
rang
worldwid
sign
undetect
earli
stage
current
effect
nafld
treatment
method
includ
exercis
diet
regul
howev
signific
proport
nafld
patient
follow
recommend
nafld
benign
diseas
substanti
proport
popul
risk
progress
diseas
sinensi
popular
dish
asia
taiwan
vegetarian
use
flavor
sinc
nontox
easili
cultiv
sinensi
wide
use
herbal
remedi
figur
effect
compound
isol
sinensi
lipid
accumul
cell
ad
nile
red
stain
data
quantifi
three
eight
independ
experi
express
mean
sd
p
compar
control
group
con
p
p
compar
ffa
group
incid
nafld
vari
rang
worldwid
sign
undetect
earli
stage
current
effect
nafld
treatment
method
includ
exercis
diet
regul
howev
signific
proport
nafld
patient
follow
recommend
nafld
benign
diseas
substanti
proport
popul
risk
progress
diseas
sinensi
popular
dish
asia
taiwan
vegetarian
use
flavor
sinc
nontox
easili
cultiv
sinensi
wide
use
herbal
remedi
tsb
tsf
also
use
tradit
medicin
studi
found
tsb
tsf
extract
block
increas
intracellular
tg
level
lipid
droplet
ffatreat
hepatocyt
fatti
acid
transport
liver
esterifi
tg
oxidis
produc
energi
howev
increas
tg
level
harm
hepatocyt
level
tsb
tsf
extract
use
studi
nontox
cell
interestingli
tsb
even
effect
fenofibr
hypolipidaem
agonist
antisteatot
effect
tsb
tsf
nafld
vivo
model
current
examin
sever
pathway
activ
tsb
andor
tsf
extract
includ
ampk
ppar
express
ampk
variou
physiolog
function
regul
energi
homeostasi
autophagi
cell
polar
cell
prolifer
previous
ampk
consid
potenti
target
nafld
treatment
activ
downstream
target
protein
pparwhil
inhibit
lxr
lxr
lipogen
activ
aris
upregul
master
regul
induct
fasn
acc
data
consist
find
tsb
tsf
extract
activ
ampk
activ
inhibit
fasn
acc
lxr
express
tg
accumul
data
show
inhibit
ampk
activ
compound
c
deterior
lipogenesi
suggest
activ
ampk
tsb
tsf
indispens
improv
lipid
accumul
ffatreat
cell
demonstr
decreas
autophagi
liver
age
associ
hepat
lipid
accumul
mammalian
homologu
upstream
compon
autophagi
pathway
autophagyiniti
kinas
ulk
directli
phosphoryl
ampk
six
differ
site
nutrient
depriv
tsb
andor
tsf
extract
induc
autophag
flux
accompani
phosphoryl
accordingli
inhibit
autophagosom
format
chloroquin
significantli
increas
lipid
accumul
ffatreat
cell
result
impli
tsb
tsf
regul
lipid
metabol
autophag
mechan
thu
upstream
key
regul
includ
mammalian
target
rapamycin
akt
examin
sinensi
compris
numer
phytochem
compon
includ
gallic
acid
methyl
gallat
ethyl
gallat
rutin
quercetin
quercitrin
kaempferol
catechin
terpenoid
tannin
present
studi
indic
tsb
tsf
extract
attenu
hepatocellular
lipid
accumul
gallic
acid
quercetin
rutin
toosendanin
activ
compon
antisteatot
effect
sinensi
extract
report
gallic
acid
quercetin
rutin
exhibit
antisteatot
effect
highfatdietf
mice
toosendanin
triterpenoid
extract
meliacea
plant
also
known
major
ingredi
meliacea
fruit
report
possess
antiadipogen
activ
preadipocyt
interestingli
toosendanin
nanomolar
rang
complet
inhibit
lipid
accumul
compound
attenu
lipid
accumul
suggest
tsb
tsf
extract
complex
ingredi
extract
contribut
partli
attenu
lipid
accumul
hepatocyt
therefor
polyphenolrich
tsb
andor
tsf
may
safe
potenti
herbal
remedi
prevent
nafld
briefli
tsb
tsf
extract
caus
cytotox
suggest
potenti
target
steatosi
either
tsb
tsb
extract
show
antilipogen
activ
improv
lipid
metabol
hepatocyt
